Position in PCRX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$5,075,852
-$1,179,284 QoQ
Shares Held
200,073
-27.7% QoQ
Ownership
0.502%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#40
of 251 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $76,204,027 across 16 Drug Manufacturers - Specialty & Generic names. PCRX ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
36,800 | $19,939,342 | |
| 2 | LQDA |
Liquidia Corp
|
210,365 | $16,772,400 | |
| 3 | ZTS |
Zoetis Inc.
|
193,922 | $13,935,230 | |
| 4 | PRGO |
PERRIGO Co plc
|
526,659 | $5,471,987 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
This page
|
200,073 | $5,075,852 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
162,812 | $3,285,546 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
92,925 | $3,148,299 | |
| 8 | VTRS |
Viatris Inc
|
164,982 | $2,619,910 |
All Filings in PCRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,075,852 | 200,073 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $6,255,136 | 276,776 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $5,757,997 | 223,438 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $5,711,454 | 238,973 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $5,820,590 | 234,229 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $4,323,497 | 229,485 | Shares | Other | 2025-01-28 | |
| 2024-09-30 | $3,285,956 | 218,336 | Shares | Other | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||